导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 27.65% | 158/1050 |
| 近一周 | -0.04% | 428/1104 |
| 近一月 | -6.88% | 678/1103 |
| 近一季 | -8.40% | 561/1094 |
| 近半年 | 28.32% | 124/1074 |
| 近一年 | 10.94% | 339/1020 |
| 近两年 | 110.68% | 169/926 |
| 近三年 | 50.40% | 264/834 |
| 成立以来 | 91.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.42% 882/1070 |
81.46% 102/1101 |
- - |
- - |
| 2025 | 13.59% 780/1065 |
8.76% 191/1014 |
-1.35% 804/1038 |
24.12% 473/1050 |
-14.71% 980/1065 |
| 2024 | 5.00% 425/1011 |
-2.90% 472/960 |
-13.99% 933/983 |
16.05% 173/991 |
8.35% 81/1011 |
| 2023 | 13.53% 15/952 |
32.47% 9/880 |
10.75% 17/895 |
-18.31% 840/915 |
-5.27% 539/952 |
| 2022 | -26.11% 533/867 |
-21.71% 623/773 |
3.24% 619/806 |
-9.87% 237/845 |
1.42% 362/867 |
| 2021 | 14.00% 196/740 |
-7.32% 430/580 |
24.73% 96/659 |
-3.83% 308/704 |
2.55% 329/740 |
| 2020 | 28.75% 354/554 |
-7.15% 342/419 |
22.52% 240/466 |
-0.33% 424/517 |
13.55% 239/554 |
| 2019 | 59.98% 81/410 |
32.97% 221/1146 |
-5.86% 768/1228 |
13.51% 64/390 |
12.59% 102/410 |
| 2018 | -24.66% 139/349 |
- - |
-15.79% 794/990 |
-6.35% 531/1000 |
-10.07% 299/1080 |
| 2017 | 10.31% 131/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 嘉实文体娱乐股票C VS. 东吴新产业精选股票A(580008) |